JPRN-UMIN000000856已完成2 期
Phase II trial of chemoradiotherapy (50.4Gy, modified 5-FU+CDDP) for clinical Stage II/III esophageal carcinoma - Stage II/III esophageal carcinoma: CRT based on the RTOG regimen Phase II
ational Cancer Center Hospital, Tokyo0 个研究点目标入组 50 人开始时间: 2007年11月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Fistula 2. Sever complications 3. Active infection 4. Past history of radiotherapy of chest 5. Intersitial pneumonia or fibrosis 6. Active double cancer 7. Pregnancy 8. Mental illness
研究者
相似试验
已完成
2 期
A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)locally advanced esophageal carcinomaJPRN-UMIN000002029Kitasato University School of Medicine35
已完成
1 期
Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)JPRN-jRCT2091220010Japan Clinical Oncology Group(JCOG)81
未知
1 期
Phase I/II Study of Satraplatin Plus RadiotherapyJPRN-jRCT2080221482Yakult Honsha Co.,Ltd.33
已完成
2 期
phase II trial of concurrent chemoradiotherapy (CCRT) with docetaxel + cisplatin + cetuximab for locally advanced squamous cell carcinoma of the head and neckadvanced squamous cell carcinoma of the head and neckJPRN-UMIN000013858Department of Biology and Function in the Head and Neck, Yokohama City University Graduate School of Medicine30
已完成
2 期
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32